MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Manur Multi Specialty Hospital successfully treats 14-year-old boy with Guillain-Barre Syndrome, AMSAN, and breathing issues.

Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

Colon cancer survivor John B. Johnson shares his journey from diagnosis to recovery and his message to young people.

The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...

A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...

The supplements could reduce hunger and appetite, as well as lower blood pressure, reduce joint inflammation and more.

Inhibiting a protein isoform in the spinal cord alongside morphine improves the opioid’s pain-relieving properties without ...

EXCLUSIVE: The former Coronation Street star has recruited help for her new role away from soap life, in fear of not being ...

India: As diabetes rates rise globally, diabetic foot care has become a vital focus in healthcare. A recent review published ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...